Diamox Tablet

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

acetazolamide, Quantity: 250 mg

Available from:

Arrow Pharma Pty Ltd

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: maize starch; calcium hydrogen phosphate dihydrate; magnesium stearate; povidone; sodium starch glycollate

Administration route:

Oral

Units in package:

250 tablets, 100 tablets

Class:

Medicine Registered

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

For adjunctive treatment of oedema due to congestive heart failure; drug induced oedema; centrencephalic epilepsies (petit mal, unlocalised seizures); chronic simple (open angle) glaucoma, secondary glaucoma and preoperatively in acute angle closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

Product summary:

Visual Identification: A white, round, convex tablet, one side plain, the other side scored into quarters.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

1991-09-09

Patient Information leaflet

DIAMOX- Consumer Medicine Information
Page 1 of 5
DIAMOX
_acetazolamide _
CONSUMER MEDICINE INFORMATION (CMI)
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about DIAMOX. It does
not
contain
all
of
the
available
information. It does not take the
place of talking to your doctor or
pharmacist.
All
medicines
have
risks
and
benefits. Your doctor has weighed
the risks of you taking DIAMOX
against the benefits they expect it
will have for you.
ASK YOUR DOCTOR OR PHARMACIST IF
YOU
HAVE
ANY
CONCERNS
ABOUT
TAKING THIS MEDICINE.
KEEP
THIS
LEAFLET
WITH
THE
MEDICINE.
You may need to read it again.
WHAT DIAMOX IS USED
FOR
DIAMOX is used to lower raised
pressure in the eye and to treat the
following forms of glaucoma:
•
Chronic
simple
(open-angle)
glaucoma
•
Secondary
glaucoma,
where
glaucoma has developed as a
result of other eye disorders
•
Acute
angle-closure
glaucoma
before undergoing surgery.
Glaucoma is the name given to a
group of eye diseases in which the
optic nerve at the back of the eye is
slowly destroyed. In most people
this damage is caused by increased
pressure in the eye. However, some
people with glaucoma may have
normal eye pressure.
Glaucoma is usually caused by a
build up of fluid which flows into
the
eye.
This
build
up
occurs
because the fluid drains out of your
eye more slowly than it is being
pumped
in.
Since
new
fluid
continues to enter the eye, joining
the fluid that is already there, the
pressure
continues
to
rise.
This
raised
pressure
may
damage
the
back
of
the
eye,
resulting
in
gradual loss of sight. Damage can
progress so slowly that the person
is not aware of this gradual loss of
sight. Sometimes even normal eye
pressure is associated with damage
to the back of the eye.
There are usually no symptoms of
glaucoma.
The
only
way
of
knowing
is
to
have
your
eye
pressure,
optic nerve, and visual
field checked by an eye specialist
or optometrist. If glaucoma is not
treated
it
can
lead
to
serious
problems.
You
may
have
no
symptoms but eventually glaucoma
can lead to total blindnes

Summary of Product characteristics

1
AUSTRALIAN PRODUCT INFORMATION – DIAMOX (ACETAZOLAMIDE)
TABLETS
1
NAME OF THE MEDICINE
Acetazolamide.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
DIAMOX tablets contain 250mg acetazolamide.
For the full list of excipients, see SECTION 6.1 LIST OF EXCIPIENTS.
3
PHARMACEUTICAL FORM
DIAMOX tablets are white, round, convex tablet, one side plain, the
other side scored into quarters.
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
For adjunctive treatment of: oedema due to congestive heart failure;
drug-induced oedema;
centrencephalic epilepsies (petit mal, unlocalized seizures); chronic
simple (open-angle) glaucoma,
secondary glaucoma and preoperatively in acute angle-closure glaucoma
where delay of surgery is
desired in order to lower intraocular pressure.
4.2
D
OSE AND METHOD OF ADMINISTRATION
GLAUCOMA
DIAMOX should be used as an adjunct to the usual therapy. The dosage
employed in the treatment
of chronic simple (open-angle) glaucoma ranges from 250 mg to 1 g per
24 hours, usually in divided
doses for amounts over 250 mg. It has usually been found that a dosage
in excess of 2 g per 24
hours does not produce an increased effect. In all cases, the dosage
should be adjusted with careful
individual attention both to symptomatology and ocular tension.
Continuous supervision by a
physician is advisable.
In treatment of secondary glaucoma and in the preoperative treatment
of some cases of acute
congestive (closed-angle) glaucoma, the preferred dosage is 250 mg
every 4 hours, although some
cases have responded to 250 mg twice daily on short-term therapy. In
some acute cases, it may be
2
more satisfactory to administer an initial dose of 500 mg followed by
125 or 250 mg every 4 hours
depending on the individual case. Intravenous therapy may be used for
rapid relief of ocular tension
in acute cases. A complementary effect has been noted when DIAMOX has
been used in conjunction
with miotics or mydriatics as the case demanded.
EPILEPSY
It is not clearly known whether the beneficial effects observed in
epilepsy are due